• Email Us: [email protected]
  • Contact Us: +1 718 874 1545
  • Skip to main content
  • Skip to primary sidebar

Medical Market Report

  • Home
  • All Reports
  • About Us
  • Contact Us

Activist investor Elliott owns “significant” stake in Toshiba as review conducted

September 30, 2021 by David Barret Leave a Comment

September 30, 2021

By Svea Herbst-Bayliss and Makiko Yamazaki

NEW YORK/TOKYO (Reuters) – Hedge fund Elliott Management said it owns a “significant” stake in troubled Japanese industrial conglomerate Toshiba Corp, which is conducting a strategic review amid pressure from other investors that could include a sale of the company.

Elliott, one of the world’s most powerful activist investors, which oversees some $48 billion in assets, has been invested in Toshiba since 2017 but recently increased its holding to just under 5%, making it a top 10 investor, people familiar with the firm’s investments said.

The New York-based firm’s announcement comes just months after Effissimo Capital Management, Farallon Capital Management and other shareholders ousted Toshiba’s chairman after the company was found to have colluded with the Japanese government to put pressure on foreign investors.

“Our investment in Toshiba reflects our strong conviction in the company’s underlying value,” Elliott, which prefers to conduct its negotiations out of the public spotlight, said in the statement.

The company is expected to update investors on its plans in the next weeks and is scheduled to release earnings in November. As those deadlines approach, Toshiba has told shareholders that it is mulling over three possible ways to try and unlock value, the sources said.

Elliott has engaged with management and the board and said in a statement the firm has been “encouraged by the constructive nature of our engagement with the company in recent months.”

A Toshiba spokesperson said the company does not disclose communications with its shareholders.

In its discussions, the sources said Elliott has sugggested to Toshiba that the company’s stock could be worth 6,000 yen, which would mark a 27% increase from Thursday’s close of 4,715 yen.

The three possible approaches for Toshiba could include an outright sale to a private equity firm, a breakup of the company led by its management team or a combination of the two options, the sources said.

Current shareholder frustration with the company might make a management-led buyout very unlikely suggesting instead that a private equity firm will play a role either as an outright buyer or a large minority investor, the sources said.

Toshiba launched a full review of its current assets after dismissing in April a $20 billion takeover bid from CVC Capital Partners. The results of the review will be presented when the company announces a new mid-term business plan in October..

Since then Toshiba has been in talks with financial and strategic investors, including U.S. private equity firm KKR & Co Inc, to seek their ideas for a new strategy.

Japan has recently become a popular hunting ground for U.S. activist investors, with Third Point targeting Sony Group and Olympus appointing three foreign directors after ValueAct took a stake in the company.

ValueAct has also invested in Nintendo and Seven & i Holdings.

Elliott too has previously engaged in Japan when it built a nearly $3 billion stake in SoftBank in early 2020. While it trimmed the stake as the stock price climbed, the hedge fund remains invested in SoftBank.

During the first half of 2021, 10 campaigns were launched at Japanese companies, data from investment bank Lazard shows.

(Reporting by Svea Herbst-Bayliss in New York, Makiko Yamazaki in Tokyo and Tiyashi Datta in Bengaluru; Editing by Kirsten Donovan, Jonathan Oatis and David Evans)

Source Link Activist investor Elliott owns “significant” stake in Toshiba as review conducted

David Barret
David Barret

Related posts:

  1. Evacuated Afghans, hoping to resettle in U.S., face extended limbo in third countries
  2. Daily Crunch: Fintech startup Jeeves snags $500M valuation after $57M Series B
  3. Tyk raises $35M for its open-source, open-ended approach to enterprise API management
  4. Honda Motor Co announces plans for eVTOL, avatar robots and space technologies

Filed Under: News

Reader Interactions

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Primary Sidebar

  • “This Story Is A Good One”: 40 Years Ago, Scientists Discovered A Hole In The Ozone Layer And Saved The Planet
  • “One Of World’s Largest Copper, Gold, And Silver Resources” Found In South America
  • Outrage Is Short-Lived: People More Likely To Resist New Rules Before They Come Into Effect
  • Birds Are Exploding In This California City – And No One Knows Why
  • Long COVID Brain Fog “Very Well Explained” By Altered Levels Of 2 Key Biomarkers
  • Experiment Appears To Confirm Mind-Bending Penrose-Terrell Effect Predicted 66 Years Ago
  • After 100 Years, Scientists Finally Find The Genetic Mutation That Makes Cats Orange
  • Nootropics: Do “Smart Drugs” Really Make You Smarter?
  • Better Solutions To Black Hole Collisions Thanks To 6-Dimensional Donuts
  • Weather Forecast On Titan: Methane Clouds With A Chance Of Showers, According To JWST
  • Tokyo Is The Biggest City In The World… Or Is It?
  • After 21 Years, Voyager 1 Fires Its Thrusters Again Thanks To Long-Distance Servicing
  • Men Have Double The Chance Of Dying From “Broken Heart Syndrome” That Women Do
  • “Copy” Of Magna Carta Bought For $27.50 Turns Out To Be A 1300 CE Original
  • Long-Lived, Carnivorous, And Freaky: Watch These Snails Lay Eggs Through Their Necks
  • This Radio Announcer Test From The 1920s Would Befuddle Even The Best English Speakers
  • Health Secretary Robert F. Kennedy Jr Says People Shouldn’t Take Medical Advice From Him
  • Tiger And Vet Survive Triple Root Canal
  • Why Are Pencils Hexagonal?
  • Why You Shouldn’t Drink Your Own Urine (Can’t Believe We Have To Write This)
  • Business
  • Health
  • News
  • Science
  • Technology
  • +1 718 874 1545
  • +91 78878 22626
  • [email protected]
Office Address
Prudour Pvt. Ltd. 420 Lexington Avenue Suite 300 New York City, NY 10170.

Powered by Prudour Network

Copyrights © 2025 · Medical Market Report. All Rights Reserved.

Go to mobile version